- Home
- SHOT vs IGC Comparison
SHOT vs IGC Comparison
Compare SHOT & IGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHOT
- IGC
- Stock Information
- Founded
- SHOT 2018
- IGC 2005
- Country
- SHOT United States
- IGC United States
- Employees
- SHOT N/A
- IGC N/A
- Industry
- SHOT Biotechnology: Pharmaceutical Preparations
- IGC Biotechnology: Pharmaceutical Preparations
- Sector
- SHOT Health Care
- IGC Health Care
- Exchange
- SHOT Nasdaq
- IGC Nasdaq
- Market Cap
- SHOT 31.4M
- IGC 29.4M
- IPO Year
- SHOT 2020
- IGC N/A
- Fundamental
- Price
- SHOT $0.42
- IGC $0.30
- Analyst Decision
- SHOT
- IGC Strong Buy
- Analyst Count
- SHOT 0
- IGC 2
- Target Price
- SHOT N/A
- IGC $3.75
- AVG Volume (30 Days)
- SHOT 583.2K
- IGC 399.9K
- Earning Date
- SHOT 03-31-2025
- IGC 03-04-2025
- Dividend Yield
- SHOT N/A
- IGC N/A
- EPS Growth
- SHOT N/A
- IGC N/A
- EPS
- SHOT N/A
- IGC N/A
- Revenue
- SHOT $652,495.00
- IGC $1,236,000.00
- Revenue This Year
- SHOT N/A
- IGC N/A
- Revenue Next Year
- SHOT N/A
- IGC $13.38
- P/E Ratio
- SHOT N/A
- IGC N/A
- Revenue Growth
- SHOT 68.01
- IGC 1.64
- 52 Week Low
- SHOT $0.42
- IGC $0.27
- 52 Week High
- SHOT $2.89
- IGC $0.91
- Technical
- Relative Strength Index (RSI)
- SHOT 33.14
- IGC 38.51
- Support Level
- SHOT $0.46
- IGC $0.29
- Resistance Level
- SHOT $0.51
- IGC $0.33
- Average True Range (ATR)
- SHOT 0.04
- IGC 0.01
- MACD
- SHOT 0.01
- IGC -0.00
- Stochastic Oscillator
- SHOT 0.06
- IGC 15.00
About SHOT Safety Shot Inc.
Safety Shot Inc is a wellness and functional beverage company. It is set to launch Safety Shot, the patented beverage that helps people feel faster by reducing blood alcohol content and boosting clarity.
About IGC IGC Pharma Inc.
IGC Pharma Inc develops advanced cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome and chronic pain. The company has two investigational drug assets targeting Alzheimer's disease, IGC-AD1 and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles. IGC-AD1 is a low-dose tetrahydrocannabinol-based formulation that is in a 146-person Phase 2 clinical trial for agitation in dementia due to Alzheimer's. IGC also markets a wellness brand, Holief, that targets women experiencing premenstrual syndrome and menstrual cramps.